Thursday 28 Mar 2024
By
main news image

KUALA LUMPUR (Oct 24): UBS analyst Nicole Goh upgraded the recommendation on IHH Healthcare Bhd to buy from neutral.

Goh raised the target price to RM6.80 from RM6.20, implying an 18 percent increase from the last regular trade. The target is 6 percent above the consensus average of RM6.41. IHH Healthcare had 9 buy recommendations, 14 holds and 2 sells before today.

Investors who followed Goh's recommendation would have received a 6.7 percent return in the past year before today, compared with the negative 9.5 percent return on the shares.

In the past five years and two months, UBS has rated IHH Healthcare sell once, buy twice and neutral once. The shares fell 3.3 percent in the period rated sell, rose an average 42 percent in the periods rated buy and fell 2.8 percent in the period rated neutral.

Analysts lowered their consensus one-year target price for the stock by 1.9 percent in the past three months. Forecasts range from RM5.08 to RM7.20.

      Print
      Text Size
      Share